Frontlight ResearchEarly access
Trial site
The Cancer & Hematology Centers
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Mesothelioma1 trial
- Metastatic breast cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 33 trials
- Phase 11 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting1 trial
- Lead sponsor
- Bristol-Myers Squibb2 trials
- Pfizer2 trials
- Eli Lilly and Company1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
- Sarcoma1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026